KSHV encoded miRNA single nucleotide polymorphisms identified in clinical samples can affect miRNA processing and level of expression by Marshall, Vickie et al.
POSTER PRESENTATION Open Access
KSHV encoded miRNA single nucleotide
polymorphisms identified in clinical samples can
affect miRNA processing and level of expression
Vickie Marshall
1*, Soo-Jin Han
2, Eugene Barsov
3, Octavio Quinones
4, Alex Ray
1, Robert Yarchoan
5, David Ott
3,
Rolf Renne
2, Denise Whitby
1
From 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
(ICMAOI)
Bethesda, MD, USA. 7-8 November 2011
MiRNAs are a class of non-coding RNA molecules
between 19-25 nucleotides in length that have been shown
to be involved in many biological processes by post-tran-
scriptionally regulating gene expression. Aberrant miRNA
expression has recently been associated with disease
including many human cancers. Kaposi’s sarcoma asso-
ciated herpesvirus (KSHV) encodes 12 miRNAs located
within the latency associated region. We previously
reported single nucleotide polymorphisms (SNP) in the
sequence of KSHV encoded mature and pre-miRNAs
from clinical samples [1]. An earlier report showed that a
SNP in mir-K12-5 resulted in increased expression of the
mature miRNA [2]. In the current study, we have analyzed
three different classes of miRNA polymorphisms to deter-
mine if any affect mature miRNA processing and expres-
sion. The identified SNPs include single and multiple
polymorphisms within the pre-miRNA transcript, single
mutations within the terminal loop, and single sequence
changes within the mature miRNA.
We used four complimentary approaches to detect dif-
ferences in miRNA processing and expression resulting
from sequence polymorphisms. Analysis of KSHV
miRNA expression levels in PEL cell lines using custom
ABI real time qPCR assays showed differential expression
that correlates with sequence variation. Lentiviral vectors
constructed to express wild type and variant pre-miRNAs
were transduced into 293T cells to make stably expres-
sing cell lines. miRNA expression was assessed using cus-
tom ABI real time qPCR assays. Luciferase reporter
assays were performed following transient transfections
of each miRNA. In addition, in vitro maturation assays
were performed to assess differences in Drosha/DGCR8
and Dicer cleavage between wild type and variant pre-
miRNAs.
Our results show that polymorphisms within the pre-
miRNA sequence can cause subtle expression differences
as in the case of KSHV miR-K12-6 or more profound
changes as observed in miR-K12-5. This is also the case
with SNPs located within the terminal loop as some miR-
NAs exhibited no discernable change, miR-K12-7 and
miR-K12-10, while others can cause a reduction in mature
miRNA transcripts as noted in miR-K12-4. Mutations
within the mature transcript appear to have the most
potential to effect mature transcript processing and
expression. The polymorphism within miR-K12-2 results
in reduction of mature miRNA levels while the multiple
changes in miR-K12-9 leads to complete loss of the
mature transcript.
Our data clearly show that SNPs can affect pre-
miRNA processing resulting in changes in mature
miRNA expression levels. The biological significance of
these phenotypic and genotypic variants merits further
study.
Author details
1Viral Oncology Section, AIDS and Cancer Virus Program, SAIC-Frederick,
National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
2Department of Molecular Genetics and Microbiology, University of Florida,
Gainesville, FL, USA.
3Retrovirus Assembly Section, AIDS and Cancer Virus
Program, SAIC-Frederick, Frederick, MD, USA.
4Data Management Services,
Inc., NCI-Frederick, Frederick, MD, USA.
5HIV and AIDS Malignancy Branch,
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
* Correspondence: marshallv1@mail.nih.gov
1Viral Oncology Section, AIDS and Cancer Virus Program, SAIC-Frederick,
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
Full list of author information is available at the end of the article
Marshall et al. Infectious Agents and Cancer 2012, 7(Suppl 1):P40
http://www.infectagentscancer.com/content/7/S1/P40
© 2012 Marshall et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Published: 19 April 2012
References
1. Marshall V, et al: Conservation of virally encoded microRNAs in Kaposi
Sarcoma-Associated Herpesvirus in primary effusion lymphoma cells
lines and in patients with Kaposi sarcoma or multicentric Castleman
disease. JID 2007, 195(5):645-59.
2. Gottwein E, et al: A novel assay for viral microRNA function identifies a
single nucleotide polymorphism that affects Drosha processing. J Virol
2006, 80(11):5321-6.
doi:10.1186/1750-9378-7-S1-P40
Cite this article as: Marshall et al.: KSHV encoded miRNA single
nucleotide polymorphisms identified in clinical samples can affect
miRNA processing and level of expression. Infectious Agents and Cancer
2012 7(Suppl 1):P40.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Marshall et al. Infectious Agents and Cancer 2012, 7(Suppl 1):P40
http://www.infectagentscancer.com/content/7/S1/P40
Page 2 of 2